<DOC>
	<DOC>NCT01652235</DOC>
	<brief_summary>The Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Single-Center Study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic aneurysms.</brief_summary>
	<brief_title>Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
	<criteria>Abdominal aortic aneurysm &gt; 5.0 cm or 2 times the normal aortic diameter Abdominal aortic aneurysm with history of growth &gt; 0.5 cm in 6 months Penetrating juxtarenal aortic ulcer &gt; 10 mm in depth and 20 mm in diameter Age &lt; 18 years Life expectancy &lt; 2 years Pregnant or breast feeding Inability or refusal to give informed consent Unwilling or unable to comply with the followup schedule Additional medical restrictions as specified in the Clinical Investigation Plan Additional anatomical restrictions as specified in the Clinical Investigation Plan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Abdominal aortic aneurysm</keyword>
	<keyword>Endovascular</keyword>
	<keyword>Fenestration</keyword>
	<keyword>Juxtarenal</keyword>
	<keyword>Off-the-shelf</keyword>
	<keyword>Pararenal</keyword>
</DOC>